日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Construction of a novel risk model for esophageal squamous cell carcinoma associated with purinergic signaling pathways and chemoradiotherapy sensitivity genes

构建与嘌呤能信号通路和放化疗敏感性基因相关的食管鳞状细胞癌新型风险模型

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2026.1746281
Zhan, Xiang; Zhou, Fengge; Yang, Yuanhui; Lei, Lingli; Li, Miao; Li, Jixian; Feng, Alei; Qu, Yan; Zeng, Renya; Yang, Zhe
信号转导
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Prognostic Value of Dynamic Lactate Dehydrogenase Trends in Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma: Retrospective Cohort Study

动态乳酸脱氢酶变化趋势在晚期食管鳞状细胞癌免疫治疗中的预后价值：回顾性队列研究

期刊:JMIR Cancer
影响因子:2.7
doi:10.2196/73576
Zhang, Baidong; Kang, Zhichao; Ding, Yi; Jing, Wang; Feng, Alei; Zeng, Renya; Li, Jianan; Zhao, Yi; Nie, Yuanliu; Zhang, Wentao; Sun, Lu; Yang, Zhe
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancer

GLS2抑制剂与铜协同作用，重编程三羧酸循环，从而在食管癌中实现铜凋亡驱动的放射增敏作用。

期刊:Experimental Hematology & Oncology
影响因子:13.5
doi:10.1186/s40164-025-00653-4
Jing, Wang; Wang, Wenhao; Ding, Yi; Zeng, Renya; Zhu, Hui; Kang, Zhichao; Feng, Alei; Yang, Zhe
凋亡
肿瘤
表观遗传
肿瘤免疫
食管癌
发表日期：2025
文献求助 收藏

Addition of bevacizumab to gefitinib plus chemotherapy as first-line therapy in EGFR L858R mutate advanced non-small cell lung cancer patients

在EGFR L858R突变的晚期非小细胞肺癌患者中，贝伐珠单抗联合吉非替尼和化疗作为一线治疗方案

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1503171
Lei, Lingli; Zhan, Xiang; Li, Jixian; Ding, Yi; Li, Jiaxin; Zhou, Fengge; Feng, Alei; Li, Xiaomei; Yang, Zhe
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutations: a prospective cohort study.

奥希替尼联合化疗与奥希替尼单药治疗伴有 EGFR 和 TP53 突变的晚期 NSCLC 患者的疗效比较：一项前瞻性队列研究

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-03422-9
Li Jixian, Zhan Xiang, Shao Mengqing, Zeng Renya, Li Jianan, Zhu Hui, Feng Alei, Yang Zhe, Jing Wang
信号转导
EGFR
P53
发表日期：2025
文献求助 收藏

Characteristics of molecular subtypes and cinical outcomes in the immunotherapy Queue of extensive-stage small cell lung cancer patients

广泛期小细胞肺癌患者免疫治疗队列中分子亚型特征及临床结局

期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-024-03221-4
Li, Jianan; Zhang, Wentao; Zhao, Yi; Li, Jixian; Nie, Yuanliu; Feng, Alei; Li, Qiang; Zhou, Fengge; Zeng, Renya; Yang, Zhe
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

A risk prognostic model for patients with esophageal squamous cell carcinoma basing on cuproptosis and ferroptosis

基于铜死亡和铁死亡的食管鳞状细胞癌患者风险预后模型

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-023-05005-5
Li, Jianan; Liu, Jixuan; Li, Jixian; Feng, Alei; Nie, Yuanliu; Yang, Zhe; Zhang, Wentao
肿瘤
肿瘤免疫
铁死亡
铜死亡
细胞生物学
发表日期：2023
文献求助 收藏

Genomic Features of Organ-Specific Metastases in Lung Adenocarcinoma

肺腺癌器官特异性转移的基因组特征

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.908759
Feng, Alei; Li, Yanjun; Li, Guangxu; Wang, Yu; Wen, Qiang; Yang, Zhe; Tian, Kaihua; Lv, Hongying; Guo, Lijie; Zhang, Shanshan; Liu, Xiaoyan; Jiang, Da
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Effects of Radiotherapy on Survival of Esophageal Cancer Patients Receiving Immunotherapy: Propensity Score Analysis and Nomogram Construction

放射治疗对接受免疫治疗的食管癌患者生存率的影响：倾向评分分析和列线图构建

期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S375821
Nie, Yuanliu; Yao, Guangyue; Li, Liang; Feng, Alei; Zhang, Wentao; Xu, Xiaoying; Li, Qiang; Yang, Zhe
食管癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2022
文献求助 收藏

Radiomics Study for Predicting the Expression of PD-L1 and Tumor Mutation Burden in Non-Small Cell Lung Cancer Based on CT Images and Clinicopathological Features

基于CT图像和临床病理特征的放射组学研究预测非小细胞肺癌中PD-L1表达和肿瘤突变负荷

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.620246
Wen, Qiang; Yang, Zhe; Dai, Honghai; Feng, Alei; Li, Qiang
肺癌
PD-L1
肿瘤
细胞生物学
肿瘤免疫
发表日期：2021
文献求助 收藏